Summary
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood
The global PSA Test market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
CLIA
ELISA
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Screening
Post-treatment Monitoring
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Summary: Get latest Market Research Reports on PSA Test. Industry analysis & Market Report on PSA Test is a syndicated market report, published as Global PSA Test Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of PSA Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.